“you can now bring a drug to clinical trials with less capital. More investment is also going into companies that are demonstrating that,”

Shreefāl Mehta · said date not stated · reported 2026-10-24

Shreefāl Mehta says AI can reduce the capital needed to bring a drug to clinical trials, attracting more investment.